Glycaemic efficacy and safety of linagliptin compared to basal bolus insulin regimen in non-cardiac surgical patients with type 2 diabetes: Linagliptin-Surgery trial

被引：0
|
作者：
Umpierrez, G. [1 ]
Vellanki, P. [1 ]
Rasouli, N. [2 ]
Baldwin, D. [3 ]
Alexanian, S. [4 ]
Anzola, I. [1 ]
Urrutia, M. [1 ]
Gomez, P. [1 ]
Cardona, S. [1 ]
Wang, H. [1 ]
Pasquel, F. [1 ]
机构：
[1] Emory Univ, Sch Med, Atlanta, GA USA
[2] Univ Colorado, Med, Denver, CO 80202 USA
[3] Rush Univ, Chicago, IL 60612 USA
[4] Boston Univ, Med, Boston, MA 02215 USA
来源：
DIABETOLOGIA | 2018年 / 61卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
769
引用
收藏
页码：S377 / S378
页数：2
相关论文
共 50 条
  • [1] Glycaemic efficacy and safety of linagliptin compared to a basal-bolus insulin regimen in patients with type 2 diabetes undergoing non-cardiac surgery: A multicentre randomized clinical trial
    Vellanki, Priyathama
    Rasouli, Neda
    Baldwin, David
    Alexanian, Sara
    Anzola, Isabel
    Urrutia, Maria
    Cardona, Saumeth
    Peng, Limin
    Pasquel, Francisco J.
    Umpierrez, Guillermo E.
    Bakhtiari, Hoda
    Wang, Cecilia Low
    Jones, Jocelyn
    Modzelewski, Katherine
    Ensminger, Elizabeth
    Haw, J. Sonya
    Fayfman, Maya
    Ramos, Clementina
    Gomez, Patricia
    DIABETES OBESITY & METABOLISM, 2019, 21 (04): : 837 - 843
  • [2] Efficacy and Safety of Linagliptin in General Surgical Patients with Type 2 Diabetes: Linagliptin Surgery Trial
    Vellanki, Priyathama
    Alexanian, Sara
    Baldwin, David
    Rasouli, Neda
    Anzola, Isabel A.
    Ramos, Clementina
    Urrutia, Maria A.
    Jones, Jocelyn
    Modzelewski, Katherine
    Ensminger, Elizabeth
    Bakhtiari, Hoda F.
    Pasquel, Francisco
    Fayfman, Maya
    Haw, Sonya
    Peng, Limin
    Umpierrez, Guillermo E.
    DIABETES, 2017, 66 : A336 - A336
  • [3] Glycaemic efficacy and safety of linagliptin for the management of non-cardiac surgery patients with type 2 diabetes in a real-world setting: Lina-Surg study
    Perez-Belmonte, Luis M.
    Osuna-Sanchez, Julio
    Millan-Gomez, Mercedes
    Lopez-Carmona, Maria D.
    Gomez-Doblas, Juan J.
    Cobos-Palacios, Lidia
    Sanz-Canovas, Jaime
    Barbancho, Miguel A.
    Lara, Jose P.
    Jimenez-Navarro, Manuel
    Rosa Bernal-Lopez, M.
    Gomez-Huelgas, Ricardo
    ANNALS OF MEDICINE, 2019, 51 (3-4) : 252 - 261
  • [4] Efficacy and Safety of Linagliptin as Add-On Therapy to Basal Insulin in Patients With Type 2 Diabetes
    Yki-Jarvinen, Hannele
    Duran-Garcia, Santiago
    Pinnetti, Sabine
    Bhattacharya, Sudipta
    Thiemann, Sandra
    Patel, Sanjay
    Woerle, Hans-Juergen
    DIABETES, 2012, 61 : A255 - A255
  • [5] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in patients with type 2 diabetes
    Lee, J.
    Duran-Garcia, S.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    DIABETOLOGIA, 2013, 56 : S355 - S355
  • [6] Efficacy and Safety of Linagliptin as Add-on to Basal Insulin in Patients with Type 2 Diabetes and Renal Impairment
    Mcgill, Janet B.
    Yki-Jarvinen, Hannele
    Duran-Garcia, Santiago
    Thiemann, Sandra
    Hehnke, Uwe
    Pinnetti, Sabine
    Patel, Sanjay
    Woerle, Hansjuergen
    DIABETES, 2014, 63 : A264 - A264
  • [7] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes
    Duran-Garcia, S.
    Lee, J.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    DIABETIC MEDICINE, 2016, 33 (07) : 926 - 933
  • [8] Linagliptin improves glycaemic control independently of diabetes duration and insulin resistance in patients with type 2 diabetes
    Patel, S.
    Weber, S.
    Emser, A.
    von Eynatten, M.
    Woerle, H. -J.
    DIABETOLOGIA, 2011, 54 : S339 - S339
  • [9] Safety and Efficacy of Linagliptin in Type 2 Diabetes Patients with Severe Renal Impairment
    Sloan, Lance
    Newman, Jennifer
    Sauce, Christophe
    Von Eynatten, Maximilian
    Patel, Sanjay
    Woerle, Hans J.
    DIABETES, 2011, 60 : A114 - A114
  • [10] Efficacy and Safety of Linagliptin in Patients with Type 2 Diabetes and Poor Glycemic Control
    Del Prato, Stefano
    Taskinen, Marja-Riitta
    Owens, David
    Von Eynatten, Maximillian
    Emser, Angela
    Patel, Sanjay
    Woerle, Hans J.
    DIABETES, 2011, 60 : A293 - A293
12345